Literature DB >> 27427300

The clinical impact of Anti-DFS70 antibodies in undifferentiated connective tissue disease: case reports and a review of the literature.

M Infantino1, F Meacci2, V Grossi2, M Manfredi2, F Li Gobbi3, P Sarzi-Puttini4, F Atzeni5, M Benucci3.   

Abstract

Anti-nuclear antibody (ANA) positivity suggests CTD but can also lead to a diagnosis of UCTD when a patient does not fulfill the CTD diagnostic criteria. An anti-dense fine speckled (DFS) immunofluorescence (IIF) pattern can be observed when using an ANA test on HEp-2 cells and is due to the presence of antibodies to the nuclear DFS70 antigen that has rarely found in CTD. Serological testing for anti-DFS70 antibodies could therefore play a very interesting negative predictive role in stratifying patients on the basis of the evolution of UCTD to CTD. We described two patients ANA and anti-DFS70 positive in which the use of new method allowing the immunoadsorption of anti-DFS70 antibodies has permitted to exclude the incorrect diagnosis of CTD.

Entities:  

Keywords:  Anti-DFS70 antibodies; Anti-nuclear antibodies; Undifferentiated connective tissue disease

Mesh:

Substances:

Year:  2017        PMID: 27427300     DOI: 10.1007/s12026-016-8836-4

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  15 in total

Review 1.  Undifferentiated CTD: a wide spectrum of autoimmune diseases.

Authors:  Marta Mosca; Chiara Tani; Linda Carli; Stefano Bombardieri
Journal:  Best Pract Res Clin Rheumatol       Date:  2012-02       Impact factor: 4.098

2.  Pattern on the antinuclear antibody-HEp-2 test is a critical parameter for discriminating antinuclear antibody-positive healthy individuals and patients with autoimmune rheumatic diseases.

Authors:  Henrique A Mariz; Emília I Sato; Silvia H Barbosa; Silvia H Rodrigues; Alessandra Dellavance; Luis E C Andrade
Journal:  Arthritis Rheum       Date:  2011-01

3.  Specific chemoluminescence and immunoasdorption tests for anti-DFS70 antibodies avoid false positive results by indirect immunofluorescence.

Authors:  Nicola Bizzaro; Elio Tonutti; Marilina Tampoia; Maria Infantino; Francesco Cucchiaro; Fiorenza Pesente; Gabriella Morozzi; Martina Fabris; Danilo Villalta
Journal:  Clin Chim Acta       Date:  2015-10-16       Impact factor: 3.786

4.  Analysis of the evolution of UCTD to defined CTD after a long term follow-up.

Authors:  Marta Mosca; Chiara Tani; Linda Carli; Alessandra Della Rossa; Rosaria Talarico; Chiara Baldini; Stefano Bombardieri
Journal:  Clin Exp Rheumatol       Date:  2012-10-18       Impact factor: 4.473

5.  HLA-associated production of anti-DFS70/LEDGF autoantibodies and systemic autoimmune disease.

Authors:  Yoshinao Muro; Yasushi Ogawa; Kazumitsu Sugiura; Yasushi Tomita
Journal:  J Autoimmun       Date:  2006-05-19       Impact factor: 7.094

6.  [Analysis of the evolution to defined connective tissue diseases of patients with "early unidifferentiated connective tissue diseases (UCTD)"].

Authors:  M Mosca; C Tani; C Neri; F Craig; A Della Rossa; C Baldini; R Talarico; L Carli; S Bombardieri
Journal:  Reumatismo       Date:  2008 Jan-Mar

7.  Anti-DFS70/LEDGF antibodies are more prevalent in healthy individuals compared to patients with systemic autoimmune rheumatic diseases.

Authors:  Michael Mahler; Todd Parker; Carol L Peebles; Luis E Andrade; Andreas Swart; Yvette Carbone; David J Ferguson; Danilo Villalta; Nicola Bizzaro; John G Hanly; Marvin J Fritzler
Journal:  J Rheumatol       Date:  2012-09-01       Impact factor: 4.666

Review 8.  Current concepts and future directions for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies.

Authors:  Michael Mahler; Pier-Luigi Meroni; Xavier Bossuyt; Marvin J Fritzler
Journal:  J Immunol Res       Date:  2014-04-27       Impact factor: 4.818

Review 9.  The clinical significance of the dense fine speckled immunofluorescence pattern on HEp-2 cells for the diagnosis of systemic autoimmune diseases.

Authors:  Michael Mahler; Marvin J Fritzler
Journal:  Clin Dev Immunol       Date:  2012-12-06

Review 10.  Automated tests of ANA immunofluorescence as throughput autoantibody detection technology: strengths and limitations.

Authors:  Pier Luigi Meroni; Nicola Bizzaro; Ilaria Cavazzana; Maria Orietta Borghi; Angela Tincani
Journal:  BMC Med       Date:  2014-03-03       Impact factor: 8.775

View more
  4 in total

1.  Novel clinical and therapeutic aspects in autoimmunity.

Authors:  Howard Amital; Abdulla Watad; Zoltán Szekanecz
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

2.  Improved accuracy in DFS pattern interpretation using a novel HEp-2 ELITE system.

Authors:  Maria Infantino; O Shovman; B Gilburd; M Manfredi; V Grossi; Maurizio Benucci; A Damiani; D Chimenti; K Malyavantham; Y Shoenfeld
Journal:  Clin Rheumatol       Date:  2019-01-07       Impact factor: 2.980

3.  Detection of autoantibodies to DSF70/LEDGFp75 in Mexican Hispanics using multiple complementary assay platforms.

Authors:  Mónica Vázquez-Del Mercado; Eduardo Gómez-Bañuelos; Rosa Elena Navarro-Hernández; Oscar Pizano-Martinez; Adan Saldaña-Millán; Efrain Chavarria-Avila; Lorena Gonzalez-Rosas; Lilia Andrade-Ortega; Miguel Angel Saavedra; Olga Lidia Vera-Lastra; Luis Javier Jara; Gabriel Medrano-Ramírez; Claudia Cruz-Reyes; Ignacio García-De la Torre; Marta Escarra-Senmarti; Lisiane Maria Enriconi-Dos Anjos; Anamika Basu; Roger Albesa; Michael Mahler; Carlos A Casiano
Journal:  Auto Immun Highlights       Date:  2016-11-24

4.  Recognition and Relevance of Anti-DFS70 Autoantibodies in Routine Antinuclear Autoantibodies Testing at a Community Hospital.

Authors:  John B Carter; Sara Carter; Sandra Saschenbrecker; Bruce E Goeckeritz
Journal:  Front Med (Lausanne)       Date:  2018-04-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.